Inflation Reduction Act targets Medicare drug prices, consumer costs


Inflation Reduction Act targets Medicare drug prices, consumer costs

Cancer and multiple sclerosis patients insured by Medicare are among those awaiting lower drug prices from the new Inflation Reduction Act.

Jackie Trapp has incurable blood cancer and takes a chemotherapy drug that cost more than $240,000 last year.

Even with a Medicare drug plan, the Muskego, Wisconsin, woman said she was charged $21,740 in out-of-pocket costs last year for Revlimid. The nest egg she and her husband built has dwindled and now the couple “lives on the edge.” 

Help Terms of Service Privacy Policy Your California Privacy Rights / Privacy Policy Our Ethical Principles Site Map

© 2022 USA TODAY, a division of Gannett Satellite Information Network, LLC.



Source link

Leave a Reply

Your email address will not be published.

MrMikeFrost

FREE
VIEW